GLIOBLASTOMA, IDH-WILDTYPE

Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.

Never miss a new study

Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear

Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 16 Not yet recruiting 3 Not yet finished but already full! 4 Completed 1 Terminated 1

Experimental drug aims to supercharge radiation against glioblastoma

Disease control Terminated

This Phase 2 trial tested a drug called ropidoxuridine, taken as a pill, to see if it could make radiation therapy more effective for people with a newly diagnosed, aggressive type of brain cancer (glioblastoma). The study enrolled 30 patients with a specific genetic marker (unme…

Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE

Phase: PHASE2 • Sponsor: Shuttle Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:05 UTC

GLIOBLASTOMA, IDH-WILDTYPE

Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear

Experimental drug aims to supercharge radiation against glioblastoma